Search for content, post, videos

Acquisitions

Agreements

Cantargia enters collaboration agreement
Cantargia enters collaboration agreement

Swedish Cantargia and Panorama Research Inc, a California based specialist antibody developer, have entered into a collaboration agreement to jointly accelerate Cantargia’s second program directed towards autoimmune and inflammatory diseases.

AstraZeneca in agreement with Recordati
AstraZeneca in agreement with Recordati

AstraZeneca has entered into an agreement with Recordati for the commercial rights to Seloken/Seloken ZOK and associated Logimax fixed-dose combination treatments in Europe. Metoprolol succinate is a beta-blocker for the

Collaborations

Recipharm, LIDDS Talk Collaboration
Recipharm, LIDDS Talk Collaboration

Recipharm has begun negotiations with the pharmaceutical company LIDDS about collaborating on making Liproca Depot® ahead of continued clinical development and a potential future market launch. The companies explained in

New Market

US approval for SciBase’s Nevisense
US approval for SciBase’s Nevisense

The US Food and Drug Administration has approved the Scibase Pre-Market Approval (PMA) for its product Nevisense. Nevisense is SciBase’s device for the early detection of malignant melanoma. With the

Financing

Business Award

Business Article